Newer targets for cancer: a review

dc.contributor.authorMahesh, R.
dc.date.accessioned2023-11-24T09:17:49Z
dc.date.available2023-11-24T09:17:49Z
dc.date.issued2011
dc.description.abstractCancer is the leading cause of death worldwide. Over 2 million people in the UK alone are currently living with the consequences of cancer and its treatment and this figure is projected to grow at more than 3% in a year. However, despite major improvements in diagnostic tools, patient management and cytotoxic therapies during the past quarter century, the impact on longterm survival has been modest. As our knowledge of the molecular biology of cancers in general has increased exponentially during the last 2 decades, multiple new targets have been identified and they provide a host of new approaches. This review addressed some of the recent approaches and idea for the treatment of cancer.en_US
dc.identifier.urihttps://pharmacologyonline.silae.it/files/newsletter/2011/vol2/086.bhatt.pdf
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13260
dc.language.isoenen_US
dc.publisherPharmacologyonlineen_US
dc.subjectPharmacyen_US
dc.subjectCanceren_US
dc.subjectTumorigenesisen_US
dc.subjectMalignanciesen_US
dc.subjectTherapeutic targetsen_US
dc.titleNewer targets for cancer: a reviewen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: